Inflammatory Bowel Disease Treatment Market Overview
The Inflammatory Bowel Disease (IBD) treatment market, comprising therapies for Crohn’s disease and ulcerative colitis, has been witnessing substantial growth due to the increasing prevalence of these conditions globally. Advanced biologics, expanding healthcare infrastructure, and growing awareness about chronic gastrointestinal disorders are pivotal drivers in shaping the market.